Results 41 to 50 of about 132,650 (237)

Knowledge-based best of breed approach for automated detection of clinical events based on German free text digital hospital discharge letters [PDF]

open access: yes, 2019
OBJECTIVES: The secondary use of medical data contained in electronic medical records, such as hospital discharge letters, is a valuable resource for the improvement of clinical care (e.g. in terms of medication safety) or for research purposes. However,
Demuth, Ilja   +4 more
core   +1 more source

Proton Pump Inhibitors: Are They a Real Threat to the Patient?

open access: yesGE: Portuguese Journal of Gastroenterology, 2018
Background: Proton pump inhibitors are among the most frequently prescribed drugs in the world and are generally considered safe. However, there is growing concern regarding their safety.
Sofia Xavier   +2 more
doaj   +1 more source

ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW

open access: yesArquivos de Gastroenterologia, 2017
BACKGROUND: Proton pump inhibitors and histamine H2 receptor antagonists are two of the most commonly prescribed drug classes for pediatric gastroesophageal reflux disease, but their efficacy is controversial.
Ângelo Zambam de MATTOS   +4 more
doaj   +1 more source

Prevalence of proton pump inhibitors drug interactions in community pharmacy: a network analysis approach.

open access: yesJornal de Assistência Farmacêutica e Farmacoeconomia, 2023
Objective: The aim of this study is to identify the prevalence of drug interaction associated with proton pump inhibitors, associated factors and drugs involved.
Lorena Maria Lima de Araujo   +5 more
doaj   +1 more source

Peculiarities of pathogenesis of gastric cancer formed in the treatment of chronic non-atrophic gastritis by proton pump inhibitors

open access: yesJournal of Education, Health and Sport, 2018
The data on the duration of use of proton pump inhibitors, the nature and duration of stress, and the timing of the first clinical and instrumentally confirmed manifestations of gastric cancer in 10 patients with chronic non-atrophic gastritis who were ...
A. A. Avramenko, S. N. Smolyakov
doaj   +3 more sources

Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma [PDF]

open access: yes, 2018
Rationale:Small bowel adenocarcinoma (SBA) is an uncommon gastrointestinal cancer, thus limited data about treatment for advanced disease are available.
Anselmi, Elisabetta   +4 more
core   +1 more source

Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?

open access: yesItalian Journal of Medicine, 2015
Proton pump inhibitors (PPIs) are the most potent drugs for reducing gastric acid secretion; so, since their release in the late 1980s, they have been recommended as the first therapeutic choice for many gastroesophageal diseases, risk reduction in or ...
Mario Visconti
doaj   +1 more source

Do proton pump inhibitors affect the biomechanical efficiency of implant?- a systematic review

open access: yesJournal of Oral Biology and Craniofacial Research, 2022
-: Purpose: This systematic review was executed to determine the influence of proton pump inhibitors on biomechanical efficiency of dental implants. Materials and methods: The comprehensive online literature search was conducted on digital database of ...
Varsha Verma
doaj   +1 more source

Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory. [PDF]

open access: yes, 2019
Proton-pump inhibitors, PPIs, are considered effective therapy for stomach acid suppression due to their irreversible inhibition of the hydrogen/potassium pump in the gastric parietal cells. They are widely prescribed and are considered safe for over-the-
Abagyan, Ruben   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy